Log in with your email address username.


[Correspondence] WHO recommendations for multidrug-resistant tuberculosis

Giovanni Sotgiu and colleagues1 (June 18, p 2486) described the choices facing national tuberculosis programmes in implementing the 2016 WHO recommendations for drug-resistant tuberculosis.2 However, they might be being unduly pessimistic about the shortened treatment regimen (9–12 months). Successful implementation of this regimen, in settings from Somalia to India, shows the potential benefit for some patients with multidrug-resistant (MDR) tuberculosis.3